E. Rubiu

Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients

P. Ferroli, G. Broggi, M. Gemma, 2022, Journal of clinical medicine.

Fluorescein sodium in the surgical treatment of pleomorphic xanthoastrocytomas: Results from a retrospective study

P. Ferroli, M. Schiariti, F. Acerbi, 2022, Frontiers in Oncology.

Fluorescein-guided surgery for the resection of pilocytic astrocytomas: A multicentric retrospective study

P. Ferroli, M. Schiariti, K. Schebesch, 2022, Frontiers in Oncology.

Next‐generation agents for fluorescence‐guided glioblastoma surgery

S. Pellegatta, F. B. Bombelli, F. Acerbi, 2023, Bioengineering & translational medicine.

Integrative approaches in spinal cord stimulation: Neuropathic pain management and motor recovery in spinal cord injury. A narrative review

E. Zekaj, R. Bonomo, F. Restelli, 2024, Brain & spine.

Diagnostic approach, therapeutic strategies, and surgical indications in intradural thoracic disc herniation associated with CSF leak, intracranial hypotension, and CNS superficial siderosis

P. Ferroli, M. Stanziano, G. Boncoraglio, 2022, Neurological Sciences.

A Benefit/Risk Assessment of Intrathecal Ziconotide in Chronic Pain: A Narrative Review

V. Nazzi, P. Veiceschi, F. Restelli, 2024, Journal of clinical medicine.